GLP-1 Tablets

Description

---

Semaglutide (GLP-1 Receptor Agonist / Incretin Mimetic Peptide)

Form: Tablet
Concentration: 500 mcg per tablet
Quantity per Bottle: 25 tablets

Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: 4,113.58 g/mol
CAS Number: 910463-68-2
Purity: ≥98% (HPLC)
Storage: Store in a cool, dry place away from light and moisture.

---

Description

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist designed to enhance glucose-dependent insulin secretion, reduce glucagon release, and slow gastric emptying.
Its extended half-life results from structural modification at position 8 (Aib substitution) and acylation with a C18 fatty diacid chain, enabling albumin binding and resistance to DPP-IV degradation.

In research settings, Semaglutide is used to explore GLP-1 receptor pharmacology, appetite regulation, and energy metabolism.
Preclinical data show potent effects on insulin sensitivity, adiposity reduction, and beta-cell preservation, making it a cornerstone incretin model for metabolic and obesity-related research.

---

Intended Use

This product is intended for laboratory research use only.
It is not for human consumption, diagnostic, or therapeutic applications.
All handling should be performed by qualified professionals in a controlled research environment.

---

Key Research Applications

• Investigation of GLP-1 receptor agonism and pancreatic signaling

• Studies on glucose tolerance, insulin release, and energy balance

• Research on appetite suppression and body-weight regulation

• Analysis of peptide analog stability, receptor affinity, and incretin signaling